Malayan filariasis is a parasitic disease caused by Brugia malayi (Malay filariasis) parasitizing the human lymphatic system, which is distributed in Asia. The clinical manifestations are recurrent lymphangitis, lymphadenitis and fever in the acute phase, and lymphedema and elephantiasis in the chronic phase, which seriously endanger the health and economic development of the population in the endemic areas. The larval stages of filarial worms are microfilariae, larvae and filarial larvae, of which microfilariae are the diagnostic stage and filarial larvae are the infective stage. It is also transmitted by mosquitoes, and microfilariae appear periodically in the peripheral blood.
Ace Therapeutics specializes in parasitology and has established a technical platform for the development of animal models of parasitic diseases, aiming to provide development and customization services for various animal models of parasitic diseases for clients worldwide. We provide animal model development services for Brugia malayi disease. This provides a good model for Brugia malayi morphology, life history and especially the molecular biology and preparation of monoclonal antibodies provided a good model.
We can set up a Brugia malayi disease model for you in SCID mouse or long-clawed gerbil, it can be used for scientific research and drug research of Malayan filariasis. If you want to know more, you are welcome to consult us.
Subcutaneous inoculation of the larvae of Anopheles malayi
Model animal selection: SCID mouse or long-clawed gerbil, Anopheles sinensis and Aedes aegypti
Other key reagents: 3.8% sodium raffinate anticoagulation.
Delivery content: experiment report and Brugia malayi disease animal model.
Test fee: please get it through online inquiry.
Ace Therapeutics is a contract service provider focused on parasitology research, providing innovative solutions and technologies for parasite detection, genetic engineering, and drug development. We support global research institutes, universities, and pharmaceutical companies in advancing their research goals.